Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds
Journal of Biological Chemistry · 2024-03 · 300 (3) · 105752
DOI: 10.1016/j.jbc.2024.105752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-03. Verfasst von Kenneth Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Ligands, Ubiquitin-Protein Ligases, Ubiquitination. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH.
Abstract (Originalsprache)
Cullin (CUL)-RING (Really Interesting New Gene) E3 ubiquitin (Ub) ligases (CRLs) are the largest E3 family. The E3 CRL core ligase is a subcomplex formed by the CUL C-terminal domain bound with the ROC1/RBX1 RING finger protein, which acts as a hub that mediates and organizes multiple interactions with E2, Ub, Nedd8, and the ARIH family protein, thereby resulting in Ub transfer to the E3-bound substrate. This report describes the modulation of CRL-dependent ubiquitination by small molecule compounds including KH-4-43, #33, and suramin, which target the CRL core ligases. We show that both KH-4-43 and #33 inhibit the ubiquitination of CK1α by CRL4CRBN. However, either compound's inhibitory effect on this reaction is significantly reduced when a neddylated form of CRL4CRBN is used. On the other hand, both #33 and KH-4-43 inhibit the ubiquitination of β-catenin by CRL1β-TrCP and Nedd8-CRL1β-TrCP almost equally. Thus, neddylation of CRL1β-TrCP does not negatively impact the sensitivity to inhibition by #33 and KH-4-43. These findings suggest that the effects of neddylation to alter the sensitivity of CRL inhibition by KH-4-43/#33 is dependent upon the specific CRL type. Suramin, a compound that targets CUL's basic canyon, can effectively inhibit CRL1/4-dependent ubiquitination regardless of neddylation status, in contrast to the results observed with KH-4-43/#33. This observed differential drug sensitivity of KH-4-43/#33 appears to echo CUL-specific Nedd8 effects on CRLs as revealed by recent high-resolution structural biology efforts. The highly diversified CRL core ligase structures may provide opportunities for specific targeting by small molecule modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Pharmacological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA; Drug Discovery Institute, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Oncological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: zhen-qiang.pan@mssm.edu.
Förderung
- NCI NIH HHS
- NIH
Zitieren
APA
Wu, K., DeVita, R. J., & Pan, Z. Q. (2024). Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds. Journal of Biological Chemistry, 300(3), 105752. https://doi.org/10.1016/j.jbc.2024.105752
Vancouver
Wu K, DeVita RJ, Pan ZQ. Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds. Journal of Biological Chemistry. 2024;300(3):105752. doi:10.1016/j.jbc.2024.105752
BibTeX
@article{Wu2024,
author = {Wu, Kenneth and DeVita, Robert J and Pan, Zhen-Qiang},
title = {Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {3},
pages = {105752},
doi = {10.1016/j.jbc.2024.105752}
}
EUVIMED